✦ LIBER ✦
9069 A risk–benefit analysis according to age using pooled data from two phase II trials of cisplatin plus S-1 for non-small-cell lung cancer in Japan
✍ Scribed by Sakai, H.; Yamamoto, N.; Ichinose, Y.; Kubota, K.; Gemma, A.; Saijo, N.; Fukuoka, M.; Niitani, H.
- Book ID
- 121936989
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 66 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.